Key facts
- This page summarizes William P. Mr. Burke's Form 4 filing for Axogen, Inc. (AXGN).
- 9 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 31 Oct 2025, 16:09.
William P. Mr. Burke - 29 Oct 2025 Form 4 Insider Report for Axogen, Inc. (AXGN)
- Reporting relationship
- Director
- Issuer ticker
- AXGN
- Reported as of
- 29 Oct 2025
- Net transaction value
- -$828,341
- SEC form
- 4
- Accepted by SEC
- 31 Oct 2025, 16:09:14 UTC
- Prior SEC filing
- 24 Oct 2025
- Next SEC filing
- 07 Nov 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Marc Began, as attorney-in-fact for William Burke
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Filing notes and source
Key filing fact
William P. Mr. Burke filed Form 4 for Axogen, Inc. (AXGN) on 31 Oct 2025.
Change
- Previous filing in this sequence was filed on 24 Oct 2025.
- Current net transaction value: -$828,341.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001682069
Primary reporting owner
Burke William P. Mr.
- Relationship
- Director
- Address
- C/O AXOGEN, INC. 13631 PROGRESS BLVD., SUITE 400, ALACHUA
- Signature
- /s/ Marc Began, as attorney-in-fact for William Burke
- Signature date
- 31 Oct 2025
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
AXGN
transaction
Common Stock
Options Exercise
- Transaction value
- $128,747
- Shares
- +20,436
- Change %
- +20436%
- Price
- $6.30
- Shares after
- 20,536
- Date
- 29 Oct 2025
- Ownership
- Direct
AXGN
transaction
Common Stock
Sale
- Transaction value
- $391,435
- Shares
- -20,436
- Change %
- -100%
- Price
- $19.15
- Shares after
- 100
- Date
- 29 Oct 2025
- Ownership
- Direct
- Footnotes
- F1
AXGN
transaction
Common Stock
Options Exercise
- Transaction value
- $161,164
- Shares
- +19,799
- Change %
- +19799%
- Price
- $8.14
- Shares after
- 19,899
- Date
- 29 Oct 2025
- Ownership
- Direct
AXGN
transaction
Common Stock
Sale
- Transaction value
- $435,578
- Shares
- -19,799
- Change %
- -99%
- Price
- $22.00
- Shares after
- 100
- Date
- 29 Oct 2025
- Ownership
- Direct
- Footnotes
- F2
AXGN
transaction
Common Stock
Options Exercise
- Transaction value
- $128,466
- Shares
- +18,248
- Change %
- +18248%
- Price
- $7.04
- Shares after
- 18,348
- Date
- 30 Oct 2025
- Ownership
- Direct
AXGN
transaction
Common Stock
Sale
- Transaction value
- $419,704
- Shares
- -18,248
- Change %
- -99%
- Price
- $23.00
- Shares after
- 100
- Date
- 30 Oct 2025
- Ownership
- Direct
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
AXGN
transaction
Derivative
Stock Option (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -20,436
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 29 Oct 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 20,436
- Exercise price
- $6.30
- Footnotes
- F3
AXGN
transaction
Derivative
Stock Option (right to purchase)
Options Exercise
- Transaction value
- $0
- Shares
- -19,799
- Change %
- -33%
- Price
- $0.000000
- Shares after
- 39,596
- Date
- 29 Oct 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 19,799
- Exercise price
- $8.14
- Footnotes
- F4
AXGN
transaction
Derivative
Employee Stock Option (right to purchase)
Options Exercise
- Transaction value
- $0
- Shares
- -18,248
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 30 Oct 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 18,248
- Exercise price
- $7.04
- Footnotes
- F5
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Explanation of responses 5 footnotes
Footnote F1
The sale reported on this Form 4 was made pursuant to a Rule 10b5-1(c) trading plan adopted March 14, 2025. The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $19.00 to $19.50 per share. The Reporting Person hereby undertakes to provide upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Footnote F2
The sale reported on this Form 4 was made pursuant to a Rule 10b5-1(c) trading plan adopted March 14, 2025.
Footnote F3
This grant vested on the first anniversary of the date of the grant, September 1, 2023.
Footnote F4
This grant vested in three equal annual installments on the annual anniversary of the grant date, July 11, 2022.
Footnote F5
This grant vested on the first anniversary of the date of the grant, June 6, 2024.